LOS ANGELES, March 22 - If there's one thing that publicly traded genomics companies may count on After Enron it is that cash is the new king.
...and receive Daily News bulletins.
Already have an account?Login Now.
Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.
Genetic genealogy has led to an arrest in another cold case, dating back to 1987.
Wired reports that 23andMe is trying to bolster its outside collaborations.
In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.